Table 2. Group comparisons of imaging parameters.
| Variables | T2DM-MCI (n=24) | T2DM-nMCI (n=23) | HCs (n=26) | PFDR |
|---|---|---|---|---|
| DTI-ALPS | 1.324±0.170‡ | 1.362±0.142‡ | 1.465±0.104 | 0.005a |
| PSMD (×10−4 mm2/s) | 2.139 (1.895, 2.306)†,‡ | 1.868 (1.777, 2.026) | 1.888 (1.776, 2.111) | 0.025b |
Data are presented as mean ± standard deviation or median (25th and 75th percentile). †, compared to the T2DM-nMCI group, P<0.05; ‡, compared to the HC group, P<0.05; a, one-way ANOVA; b, Kruskal-Wallis test. ANOVA, analysis of variance; DTI-ALPS, diffusion tensor imaging along the perivascular space; FDR, false discovery rate; HCs, healthy controls; PSMD, peak width of skeletonized mean diffusivity; T2DM-MCI, type 2 diabetes mellitus with mild cognitive impairment; T2DM-nMCI, type 2 diabetes mellitus without mild cognitive impairment.